Cookie Consent by PrivacyPolicies.com

March 4, 2022

The Final implementation of data access tools and DICOM visualization tool have been completed.

Date: March 4th 2022

The development of the activities related to the final implementation of data access tools and DICOM visualization tool has been accomplished.


This work updates the previous tasks performed in the Beta version of access tools, reporting the final access tools developed and integrated in the platform from a functional perspective. The final updates, changes, improvements, and decisions made were based on the feedback provided by HUTER researchers and bioinformaticians during the project.


Furthermore we provide an overview of the work performed in terms of final tools that were developed and integrated in the HUTER platform. These tools will allow researchers to interact with data in different ways (uploading, downloading, visualization, analysis, processing and so forth) and therefore improve their workflows and facilitate their scientific tasks.


Access our last report to learn more at this link


About the Human Uterus Cells Atlas – HUTER


The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women´s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.


The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity such as preeclampsia.


HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.


Link to the project website: https://huter-hca.eu/